ISPOR Initiatives

ISPOR Patient Reported Outcomes
Quality of Life
Population Health

 

PATIENT REPORTED OUTCOMES 

April 2006 ISPOR Comments on FDA Guidance for Industry – Patient Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims http://www.ispor.org/workpaper/ISPOR%20Response%20to%20FDA%20PRO%20Guidance.pdf
March 2005

Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation
Published in Value in Health, Vol. 8, Issue 2, 2005 pp 95-104  http://www.ispor.org/workpaper/research_practices/PROTranslation_Adaptation.pdf

September 2003

Incorporating the Patient’s Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001
Published in Value in Health Vol. 6 Issue 5, 2003 pp 522-531 

May 2002

Patient Reported Outcomes “PRO’ Symposium: Conceptual and Methodological Issues, May 19, 2002 (ISPOR pre-meeting symposium) http://www.ispor.org/meetings/va0502/symposium.asp 

  QUALITY OF LIFE
February 2001

Health-related Quality of Life Harmonization Meeting, FDA, February 16, 2001http://www.ispor.org/news/articles/0704/patientrep.htm

May 2000 Quality of Life Promotional Claims: Methodological Issues and Potential Solutions ISPOR pre-meeting Symposium, May 21, 2000
http://www.ispor.org/meetings/ql0500/index_.asp
March 2000

Health-related Quality of Life Harmonization Meeting (Mapi Research Institute, ERIQA Group, and PhRMA HOC) 

April 1999

Quality of Life Promotional and Label Claim Issues for Drugs, Biologicals, and Devices Report Issues and Comments published at: http://www.ispor.org/workpaper/consensus/index.asp#issue1

Development of a Consensus Document as a Supporting Document for FDA and Other Health Regulatory Authorities on Health-Related Quality of Life Guidances: Issues identified and comments given at: http://www.ispor.org/consensus_index.asp

March 1999

Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and Promotion by Nancy K Leidy, Dennis Ricki, and Bernard Geneste
Published in Value in Health  Vol. 2, Issue 2, March-April 1999

 

POPULATION HEALTH  

May 2003

Summary Measure of Population Health: A Working Group Meeting Pre-meeting workshop May 17, 2003
http://www.ispor.org/sigs/qol_ph.asp

April 2001

Summary Measures of Population Health Status - WHO Cares? by Paul Kind MPhil, University of York, York, UK and the ISPOR Quality of Life SIG http://www.ispor.org/news/articles/0702/measures_.html

October 2000

The Joint United Nations Economic Commission for Europe and World Health Organization Meeting on Measuring Health Status, October 23-25, 2000 co-hosted by Statistics Canada, held in Ottawa, Ontario, Canada
Paul Kind attended as the ISPOR representative.

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.